Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Recruiting Not applicable

Clinical Efficacy of a Natural Biopolymer-Based Irrigant

NCT07901127 · tracked via the Priya Life Science Egypt tracker
Phase
Not applicable
Started
2026-01-05
Last updated
2026-10-28

Condition(s) studied

Postoperative Pain

Investigational drug(s) / intervention(s)

Chitosan Nanoparticles

Chitosan Nanoparticles: To evaluate the incidence and intensity of postoperative pain and acute exacerbations following root canal debridement using Apical Negative Pressure-mediated Chitosan nanoparticles versus Sodium Hypochlorite.

Study summary

One primary objective in the root canal treatments is to ensure chemo mechanical removal of microorganisms and organic/inorganic tissue residues from the infected root canals. Studies in the literature report that due to the structure of the root canals, mechanical instrumentation alone could not perform a satisfying cleaning in the canal. some areas have remained unreached and infected, thus irrigation has played a key role in the achievement of root canal treatments.

Eligibility

Sex
ALL
Min age
18 Years
Max age
40 Years
Healthy volunteers
No
Inclusion Criteria: * 18 years old or older single rooted teeth(oval shaped canals). * Subjects without any relative or absolute contraindication to endodontic treatment as tooth hypermobility (grade III), or presence of untreatable longitudinal fracture. * Clinical diagnosis of asymptomatic pulp necrosis: non-responsive to thermal pulp testing. No pain to percussion or radiographic evidence of osseous breakdown. * Patients who were able to sign an informed consent form. * Subjects classified as ASA-1 following the classification proposed by the American Society of Anesthesiologists. Exclusion Criteria: * Patients taking analgesics or anti-inflammatory drugs in the seven days before intervention * Patients with vital teeth, apical periodontitis, periapical radiolucency, retreatments, root resorption, immature/open apex, or a root canal in which the is no patency to the apical foramen.

Primary outcome measure(s)

  • Post Operative Pain — 7 days
    Assessment of the participants after the treatment from pain using numerical rating scale (NRS) to record their assessment of pain after (12) hours, then every day up to 7 days.Patients will be instructed to attribute a value to their perceived pain based on the NRS, which is a pain screening tool, commonly used to assess pain severity at that moment in time using a 0-10 scale, with zero meaning "no pain" and 10 meaning "the worst pain.

Trial sites (1)

FacilityCityRegionStatus
Endodontics Department Faculty of Dentistry Minya Egypt Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07901127 on ClinicalTrials.gov ↗ ← All trials in Egypt